Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 445 to 448 of 448 entries
Sorted by: Best Match Show Resources per page
[Screening for Problematic Alcohol Consumption - A Survey on Guideline Implementation in Transdisciplinary Health Care of a Model Region].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))

Frischknecht U, Hoffmann S, Steinhauser A, Lindemann C, Buchholz A, Manthey J, Schulte B, Rehm J, Kraus L, Verthein U, Reimer J, Kiefer F.
PMID: 33302318
Gesundheitswesen. 2022 Jan;84(1):43-51. doi: 10.1055/a-1276-0475. Epub 2020 Dec 10.

AIM: Recording the frequency of screenings for problematic alcohol consumption by professionals involved in the health care of respective patients. The German S3-guideline "screening, diagnosis and treatment of alcohol-related disorders" recommends the use of questionnaire-based screenings for all patients...

Cite
Frischknecht U, Hoffmann S, Steinhauser A, et al. Screening auf problematischen Alkoholkonsum – Erhebung zur Umsetzung der S3-Leitlinienempfehlungen in der transdisziplinären Versorgung einer Modellregion. [Screening for Problematic Alcohol Consumption - A Survey on Guideline Implementation in Transdisciplinary Health Care of a Model Region]. Gesundheitswesen. 2020;84(1):43-51doi: 10.1055/a-1276-0475.
Frischknecht, U., Hoffmann, S., Steinhauser, A., Lindemann, C., Buchholz, A., Manthey, J., Schulte, B., Rehm, J., Kraus, L., Verthein, U., Reimer, J., & Kiefer, F. (2022). Screening auf problematischen Alkoholkonsum – Erhebung zur Umsetzung der S3-Leitlinienempfehlungen in der transdisziplinären Versorgung einer Modellregion. [Screening for Problematic Alcohol Consumption - A Survey on Guideline Implementation in Transdisciplinary Health Care of a Model Region]. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)), 84(1), 43-51. https://doi.org/10.1055/a-1276-0475
Frischknecht, Ulrich, et al. "Screening auf problematischen Alkoholkonsum – Erhebung zur Umsetzung der S3-Leitlinienempfehlungen in der transdisziplinären Versorgung einer Modellregion." [Screening for Problematic Alcohol Consumption - A Survey on Guideline Implementation in Transdisciplinary Health Care of a Model Region]. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) vol. 84,1 (2022): 43-51. doi: https://doi.org/10.1055/a-1276-0475
Frischknecht U, Hoffmann S, Steinhauser A, Lindemann C, Buchholz A, Manthey J, Schulte B, Rehm J, Kraus L, Verthein U, Reimer J, Kiefer F. Screening auf problematischen Alkoholkonsum – Erhebung zur Umsetzung der S3-Leitlinienempfehlungen in der transdisziplinären Versorgung einer Modellregion. [Screening for Problematic Alcohol Consumption - A Survey on Guideline Implementation in Transdisciplinary Health Care of a Model Region]. Gesundheitswesen. 2022 Jan;84(1):43-51. doi: 10.1055/a-1276-0475. Epub 2020 Dec 10. German. PMID: 33302318.
Copy Download .nbib Format: NLM
Corrigendum to "De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel": [Annals of Oncology 28 (2017) 2768-2772].

Annals of oncology : official journal of the European Society for Medical Oncology

Nitz UA, Gluz O, Christgen M, Grischke EM, Augustin D, Kuemmel S, Braun M, Potenberg J, Kohls A, Krauss K, Stefek A, Schumacher C, Forstbauer H, Reimer T, Fischer H, Liedtke C, Wuerstlein R, Schumacher J, Kates R, Kreipe H, Harbeck N.
PMID: 35012798
Ann Oncol. 2022 Jan 07; doi: 10.1016/j.annonc.2021.12.008. Epub 2022 Jan 07.

No abstract available.

Cite
Nitz UA, Gluz O, Christgen M, et al. Corrigendum to "De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel": [Annals of Oncology 28 (2017) 2768-2772]. Ann Oncol. 2022;doi: 10.1016/j.annonc.2021.12.008.
Nitz, U. A., Gluz, O., Christgen, M., Grischke, E. M., Augustin, D., Kuemmel, S., Braun, M., Potenberg, J., Kohls, A., Krauss, K., Stefek, A., Schumacher, C., Forstbauer, H., Reimer, T., Fischer, H., Liedtke, C., Wuerstlein, R., Schumacher, J., Kates, R., Kreipe, H., Harbeck, N. (2022). Corrigendum to "De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel": [Annals of Oncology 28 (2017) 2768-2772]. Annals of oncology : official journal of the European Society for Medical Oncology, . https://doi.org/10.1016/j.annonc.2021.12.008
Nitz, U A, et al. "Corrigendum to "De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel": [Annals of Oncology 28 (2017) 2768-2772]." Annals of oncology : official journal of the European Society for Medical Oncology vol. (2022). doi: https://doi.org/10.1016/j.annonc.2021.12.008
Nitz UA, Gluz O, Christgen M, Grischke EM, Augustin D, Kuemmel S, Braun M, Potenberg J, Kohls A, Krauss K, Stefek A, Schumacher C, Forstbauer H, Reimer T, Fischer H, Liedtke C, Wuerstlein R, Schumacher J, Kates R, Kreipe H, Harbeck N. Corrigendum to "De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel": [Annals of Oncology 28 (2017) 2768-2772]. Ann Oncol. 2022 Jan 07; doi: 10.1016/j.annonc.2021.12.008. Epub 2022 Jan 07. PMID: 35012798.
Copy Download .nbib Format: NLM
The sentinel node invasion level (SNIL) as a prognostic parameter in melanoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Kretschmer L, Mitteldorf C, Hellriegel S, Leha A, Fichtner A, Ströbel P, Schön MP, Bremmer F.
PMID: 34131294
Mod Pathol. 2021 Oct;34(10):1839-1849. doi: 10.1038/s41379-021-00835-5. Epub 2021 Jun 15.

Sentinel lymph node (SN) tumor burden is becoming increasingly important and is likely to be included in future N classifications in melanoma. Our aim was to investigate the prognostic significance of melanoma infiltration of various anatomically defined lymph node...

Cite
Kretschmer L, Mitteldorf C, Hellriegel S, et al. The sentinel node invasion level (SNIL) as a prognostic parameter in melanoma. Mod Pathol. 2021;34(10):1839-1849doi: 10.1038/s41379-021-00835-5.
Kretschmer, L., Mitteldorf, C., Hellriegel, S., Leha, A., Fichtner, A., Ströbel, P., Schön, M. P., & Bremmer, F. (2021). The sentinel node invasion level (SNIL) as a prognostic parameter in melanoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 34(10), 1839-1849. https://doi.org/10.1038/s41379-021-00835-5
Kretschmer, Lutz, et al. "The sentinel node invasion level (SNIL) as a prognostic parameter in melanoma." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 34,10 (2021): 1839-1849. doi: https://doi.org/10.1038/s41379-021-00835-5
Kretschmer L, Mitteldorf C, Hellriegel S, Leha A, Fichtner A, Ströbel P, Schön MP, Bremmer F. The sentinel node invasion level (SNIL) as a prognostic parameter in melanoma. Mod Pathol. 2021 Oct;34(10):1839-1849. doi: 10.1038/s41379-021-00835-5. Epub 2021 Jun 15. PMID: 34131294; PMCID: PMC8443441.
Copy Download .nbib Format: NLM
Lysosomal lipoprotein processing in endothelial cells stimulates adipose tissue thermogenic adaptation.

Cell metabolism

Fischer AW, Jaeckstein MY, Gottschling K, Heine M, Sass F, Mangels N, Schlein C, Worthmann A, Bruns OT, Yuan Y, Zhu H, Chen O, Ittrich H, Nilsson SK, Stefanicka P, Ukropec J, Balaz M, Dong H, Sun W, Reimer R, Scheja L, Heeren J.
PMID: 33357458
Cell Metab. 2021 Mar 02;33(3):547-564.e7. doi: 10.1016/j.cmet.2020.12.001. Epub 2020 Dec 22.

In response to cold exposure, thermogenic adipocytes internalize large amounts of fatty acids after lipoprotein lipase-mediated hydrolysis of triglyceride-rich lipoproteins (TRL) in the capillary lumen of brown adipose tissue (BAT) and white adipose tissue (WAT). Here, we show that...

Cite
Fischer AW, Jaeckstein MY, Gottschling K, et al. Lysosomal lipoprotein processing in endothelial cells stimulates adipose tissue thermogenic adaptation. Cell Metab. 2020;33(3):547-564.e7doi: 10.1016/j.cmet.2020.12.001.
Fischer, A. W., Jaeckstein, M. Y., Gottschling, K., Heine, M., Sass, F., Mangels, N., Schlein, C., Worthmann, A., Bruns, O. T., Yuan, Y., Zhu, H., Chen, O., Ittrich, H., Nilsson, S. K., Stefanicka, P., Ukropec, J., Balaz, M., Dong, H., Sun, W., Reimer, R., Scheja, L., & Heeren, J. (2021). Lysosomal lipoprotein processing in endothelial cells stimulates adipose tissue thermogenic adaptation. Cell metabolism, 33(3), 547-564.e7. https://doi.org/10.1016/j.cmet.2020.12.001
Fischer, Alexander W, et al. "Lysosomal lipoprotein processing in endothelial cells stimulates adipose tissue thermogenic adaptation." Cell metabolism vol. 33,3 (2021): 547-564.e7. doi: https://doi.org/10.1016/j.cmet.2020.12.001
Fischer AW, Jaeckstein MY, Gottschling K, Heine M, Sass F, Mangels N, Schlein C, Worthmann A, Bruns OT, Yuan Y, Zhu H, Chen O, Ittrich H, Nilsson SK, Stefanicka P, Ukropec J, Balaz M, Dong H, Sun W, Reimer R, Scheja L, Heeren J. Lysosomal lipoprotein processing in endothelial cells stimulates adipose tissue thermogenic adaptation. Cell Metab. 2021 Mar 02;33(3):547-564.e7. doi: 10.1016/j.cmet.2020.12.001. Epub 2020 Dec 22. PMID: 33357458.
Copy Download .nbib Format: NLM
Showing 445 to 448 of 448 entries